• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Prescription Drug Diversion and Pain

Prescription Drug Diversion and Pain

History, Policy, and Treatment

9780199981830
386,10 zł
347,49 zł Zniżka 38,61 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 347,49 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
Prescription Drug Diversion and Pain provides an interdisciplinary overview of medications used to treat chronic pain, specifically the benefits and risks that are posed by long-term opioids use. These essential pain-relieving medications must be carefully managed to prevent serious side effects that may include physical dependence, addiction, and even death, which has led in recent years to increased attention on the development of alternative treatments for chronic pain.This book not only offers a single, comprehensive source for understanding the specialized field of the opioid crisis, but also addresses provocative topics including how pain drugs came to be regulated by the U.S. Government and the rarely-discussed aggressive marketing behind the spread of these drugs.Chapters are written by expert contributors from diverse backgrounds in medicine, psychiatry, pharmacy, nursing, health law, and ethics. Prescription Drug Diversion and Pain is a must-read for healthcare professionals, caregivers, policy makers, regulatory officials, law enforcement, and those in the pharmaceutical industry seeking to address the current and future opioid crisis.
Szczegóły produktu
OUP USA
87923
9780199981830
9780199981830

Opis

Rok wydania
2018
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
272
Wymiary (mm)
178 x 254
Waga (g)
499
  • John F. Peppin, John J. Coleman, and Kelly K. Dineen; Chapter 1: Opioid Medications: Old Wine in New Bottles; Timothy Atkinson, John J. Coleman, and Jeffrey Fudin; Chapter 2: Legal Regulation of Prescription Opioids and Prescribers; Kelly K. Dineen and Adam J. Ruggles; Chapter 3: Monitoring Prescriptions, Third-Party Healthcare Payers, Prescription Benefit Managers, and Private Sector Policy Options; John J. Coleman; Chapter 4: Whatever Happened to the Decade of Pain Control and Research?; John J. Coleman; Chapter 5: Evaluation and Treatment of the Chronic Pain Patient: Practice and Complexity; John F. Peppin, Pravardhan Birthi, Bill H. McCarberg, and Yvonne DArcy; Chapter 6: An Overview of the Abuse Potential of Non-Opioids: Sedatives, Hypnotics, and Stimulants; Christopher M. Herndon and Kelly N. Gable; Chapter 7: Psychiatry and Chronic Pain: An Associative Connection; Hani Raoul Khouzam; Chapter 8: Managing Pain in Patients with a History of a Substance Use Disorder: Challenges and Opportunities; Martin D. Cheatle; Chapter 9: Special Populations; Kelly K. Dineen; Chapter 10: The Demise of Interdisciplinary Chronic Pain Management and Its Relationship to the Scourge of Prescription Opioid Diversion and Abuse; Michael E. Schatman; Chapter 11: Pain Management Assessment Beyond the Physician Encounter: Urine Drug Monitoring and Patient Agreements; Anand C. Thakur; Epilogue; John F. Peppin, John J. Coleman, and Kelly K. Dineen;
Komentarze (0)